Onco-Innovations Unaware of Any Material Change

Arizona Tribune - Onco-Innovations Unaware of Any Material Change

Onco-Innovations Unaware of Any Material Change

VANCOUVER, BC / ACCESS Newswire / January 24, 2025 / At the request of the Canadian Investment Regulatory Organization, Onco-Innovations Limited (the "Company") wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.

Text size:

About Onco-Innovations Limited

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to prevent and cure cancer through pioneering research and innovative solutions. The Company has secured an exclusive worldwide license to patented technology that targets solid tumours, setting new standards in cancer treatment. Onco's commitment to excellence and innovation drives it to develop advanced therapies that improve patient outcomes and offer hope in the fight against cancer.

ON BEHALF OF ONCO-INNOVATIONS LIMITED,

"Thomas O'Shaughnessy"

Chief Executive Officer

For more information, please contact:

Thomas O'Shaughnessy
Chief Executive Officer
Tel: + 1 888 261 8055
[email protected]

The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.

Forward-Looking Statements Caution. This news release may contains forward-looking statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "potential", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

SOURCE: Onco-Innovations Limited

View the original press release on ACCESS Newswire

O.Ortiz--AT

CMSC	-0.53%	20.81	$
JRI	-0.58%	12.14	$
CMSD	-0.34%	20.69	$
BCC	2.64%	79.21	$
BTI	-1.12%	55.35	$
RIO	0.42%	103.27	$
BCE	-0.59%	23.67	$
RBGPF	0%	70	$
NGG	-0.06%	78.12	$
GSK	-1.96%	49.89	$
RYCEF	0.7%	19.92	$
RELX	-3.21%	35.51	$
BP	0.52%	43.81	$
VOD	1.89%	16.9	$
AZN	-1.27%	162.7	$

Arizona Tribune - Onco-Innovations Unaware of Any Material Change

Onco-Innovations Unaware of Any Material Change

Featured

Ethiopian Miss World contestant spotlights pain of sister's murder

Nepal tunnel rescue revives hopes 10 days after flood

How haze from Indonesian fires impacts Southeast Asia

New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST)